Protheragen - Products
Protheragen provides active pharmaceutical ingredients (APIs), chemicals, natural extracts, intermediates, pharmaceutical excipients, and veterinary chemicals
| Product | Description | |
|---|---|---|
| Ketorolac Tromethamine | Ketorolac tromethamine is a potent, nonsteroidal anti-inflammatory drug (NSAID) with prominent analgesic properties. It is a member of the pyrrolo-pyrrole group of NSAIDs and is chemically designated as (±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1). Applications: Ketorolac tromethamine is indicated for specific, short-term clinical scenarios. its use is governed by strict dosing limits and contraindications to mitigate serious risks. it is fda-approved for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, often in the postoperative setting. for ophthalmic use, ketorolac tromethamine ophthalmic solution is indicated for the temporary relief of ocular itching due to seasonal allergic conjunctivitis. Category: Nonsteroidal anti-inflammatory (nsaid) apis. Synonyms: Ketorolac (+/-)-form tromethamine salt / Ketorolac trometamol. Grades: USDMF/CEP. CAS No. 74103-07-4. Product ID: API74103074. Molecular formula: C19H24N2O6. Mole weight: 376.4. EINECS: 620-545-3. InChIKey: BWHLPLXXIDYSNW-UHFFFAOYSA-N. Standard: USP;Facility GMP;Product GMP. |  |
| Ketorolac Tromethamine Intermediate | Ketorolac Tromethamine Intermediate. Category: Intermediates. CAS No. 7696-46-3. Product ID: API7696463. | |
| Konjac Glucomannan | Konjac Glucomannan belongs to the family of long-chain polymers extracted from the root of the Konjac plant. It is a dietary fiber made of glucose and mannose. Chemically a neutral soluble fiber with high viscosity, glucomannan has high thermal gel strength. Its principal use is as a dietary fiber supplement. Applications: Konjac glucomannan has been used in drug delivery systems as a binder, disintegrant, and coating agent. it has also been used to create formulations that help increase the feeling of fullness in weight loss supplements. konjac glucomannan also finds its use as a thickener/film former in cosmetic formulations. Category: Natural extract. Synonyms: Konjac Gum; KGM. CAS No. 37220-17-0. Product ID: PIPE-0246. EINECS: 253-404-6. Appearance: Solid. Standard: In house. | |
| Labetalol Hydrochloride | Labetalol hydrochloride is a unique antihypertensive agent that combines non-selective beta-adrenergic blockade with selective alpha-1 adrenergic antagonism. It lowers blood pressure without causing reflex tachycardia. The drug is particularly useful in hypertensive emergencies and pregnancy-induced hypertension. Applications: Labetalol is indicated for the management of hypertension, including hypertensive emergencies (via iv) and chronic essential hypertension (oral). it is the preferred agent for gestational hypertension and preeclampsia due to its safety profile during pregnancy. the drug also treats intraoperative hypertension and pheochromocytoma-related hypertension. Category: Active pharmaceutical ingredients. Synonyms: Labetalol HCL; Labrocol; ScH 15719W; AH 5158A; Ibidomide hydrochloride; Sch-15719W; 1GEV3BAW9J. CAS No. 32780-64-6. Product ID: API0231620. Molecular formula: C19H25ClN2O3. Mole weight: 364.9. EINECS: 276-694-6. InChIKey: WQVZLXWQESQGIF-UHFFFAOYSA-N. Appearance: White or off-white crystalline powder. | |
| Lactic Acid | Lactic Acid (2-hydroxypropanoic acid) is a naturally occurring organic acid produced through anaerobic metabolism of glucose via lactic fermentation. It exists in two enantiomeric forms: L-(+)-lactic acid (produced biologically) and D-(-)-lactic acid, with the L-form predominating in mammalian physiology. Applications: Used as a pharmaceutical excipient, acidifying agent, and ph modifier in topical formulations, parenteral solutions, and cosmetic products. lactic acid also serves as a building block for biodegradable polymers such as pla and as a chiral intermediate in pharmaceutical synthesis. Category: Active pharmaceutical ingredients. Synonyms: 2-Hydroxy-2-methylacetic acid. CAS No. 50-21-5. Product ID: API50215. Molecular formula: C3H6O3. Mole weight: 90.08. EINECS: 200-018-0. InChIKey: JVTAAEKCZFNVCJ-UHFFFAOYSA-N. Appearance: Colorless to yellow syrup. | |
| Lactoferrin | Lactoferrin. Category: Natural extract. Synonyms: COLOSTRUM;LACTOSIDEROPHILIN (BOVINE);LACTOTRANSFERRIN (BOVINE);LACTOFERRIN, HUMAN;LACTOFERRIN, HUMAN MILK;LACTOFERRIN (BOVINE). CAS No. 146897-68-9. Product ID: PIPE-0358. Molecular formula: C141H224N46O29S3. Mole weight: 3123.82. Appearance: Powder. | |
| Lactose | Lactose. Applications: Lactose is used in large quantities as a drug excipient, as a nutrient for infants and young children, and as a good medium for penicillin. it is used as a diluent for soluble powder dispersions, oral capsules, powder inhalers and tablets; lactose is also used in lyophilisates and intravenous injections. Category: Pharmaceutical excipients. Synonyms: A-MILK SUGAR;(+)-4-O-β-D-Galactopyranosyl-α-D-glucopyranose;4-O-β-D-Galactopyranosyl-α-D-glucopyranose;D-(+)-Lactose Monohydrate (alpha-form);lactose bp/usp;Lactose IP/BP;A-LACTOBIOSE USP;A-LACTIN USP. CAS No. 14641-93-1. Product ID: PIE-0053. Molecular formula: C12H22O11. Mole weight: 342.3. Appearance: White fine crystals. Standard: USP/ChP. | |
| LaflunimusHR325 | Laflunimus suppresses immunoglobulin (Ig) secretion, with IC50 values of 2.5 and 2 μM for IgM and IgG, respectively. Laflunimus also is a prostaglandin endoperoxide H synthase (PGHS) -1 and -2 inhibitor. Laflunimusis an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). Category: Active pharmaceutical ingredients. CAS No. 147076-36-6. Product ID: API147076366. Molecular formula: C15H13F3N2O2. Mole weight: 310.27. | |
| Lamivudine | Lamivudine is a potent reverse transcriptase inhibitor. Category: Active pharmaceutical ingredients. Grades: USMF/CEP/KDMF. CAS No. 134678-17-4. Product ID: API134678174. Molecular formula: C8H11N3O3S. Mole weight: 229.26. SMILES: C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N. Appearance: Powder. Standard: Facility GMP. | |
| Landiolol HCl | Landiolol hydrochloride is a highly beta1 selective ultra-short acting beta-blocker (β1/β2 selectivity?=?255:1, a half-life of 4?min), acts as an adrenoceptor antagonist. Category: Active pharmaceutical ingredients. CAS No. 144481-98-1. Product ID: API144481981. Molecular formula: C25H40ClN3O8. Mole weight: 546.053. | |
| Lansoprazole | Lansoprazole (A-65006) is a 2, 2, 2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor). Category: Active pharmaceutical ingredients. CAS No. 103577-45-3. Product ID: API103577453. Molecular formula: C16H14F3N3O2S. Mole weight: 369.36. | |
| Lansoprazole-d4 | Lansoprazole D4 (AG-1749 D4) is a deuterium labeled Lansoprazole. Lansoprazole is an inhibitor of proton pump which prevents the stomach from producing acid. Category: Active pharmaceutical ingredients. CAS No. 934294-22-1. Product ID: API934294221. Molecular formula: C16H14F3N3O2S. Mole weight: 373.39. | |
| Lansoprazole N-oxide | Lansoprazole N-oxide is a potential impurity in lansoprazole bulk preparations, identified as a degradation product under acidic or basic conditions. This compound is related to lansoprazole, a proton pump inhibitor. Category: Active pharmaceutical ingredients. CAS No. 213476-12-1. Product ID: API213476121. Molecular formula: C16H14F3N3O3S. Mole weight: 385.36. | |
| Lansoprazole sodium | Lansoprazole sodium (Lansoprazole (sodium)) is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity which is widely used in the therapy of gastroesophageal reflux and peptic ulcer disease. Category: Active pharmaceutical ingredients. CAS No. 226904-00-3. Product ID: API226904003. Molecular formula: C16H13F3N3NaO2S. Mole weight: 391.34. | |
| Lansoprazole sulfide | Lansoprazole sulfide is an impurity of Lansoprazole, which is a gastric pump inhibitor. Category: Active pharmaceutical ingredients. Synonyms: Lansoprazole impurity C,AG-1777,EC 600-451-9,H 225 18,K-1252. CAS No. 103577-40-8. Product ID: API103577408. Molecular formula: C16H14F3N3OS. Mole weight: 353.36. | |
| Lansoprazole Sulfide D4 | Lansoprazole Sulfide D4 is a deuterium labeled Lansoprazole Sulfide. Lansoprazole Sulfide is an orally active anti-TB (Mycobacterium tuberculosis) agent with IC50 values of 0.59 μM intracellularly and 0.46 μM in broth.Lansoprazole Sulfide is an active metabolite of the proton pump inhibitor Lansoprazole. Category: Active pharmaceutical ingredients. CAS No. 1216682-38-0. Product ID: API1216682380. Molecular formula: C16H14F3N3OS. Mole weight: 357.39. | |
| Lansoprazole sulfone | Lansoprazole sulfone is a metabolite of the gastric pump inhibitor Lansoprazole. Category: Active pharmaceutical ingredients. CAS No. 131926-99-3. Product ID: API131926993. Molecular formula: C16H14F3N3O3S. Mole weight: 385.36. | |
| Lanthanum Carbonate | Lanthanum Carbonate. Category: Other apis. Synonyms: Lanthanum carbonate octahydrate. UNII-29J24L6P7N. 29J24L6P7N. lanthanum(III) carbonate octahydrate. CAS No. 6487-39-4. Product ID: API6487394. Molecular formula: C3H16La2O17. Mole weight: 601.96. SMILES: C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].O.O.O.O.O.O.O.O.[La+3].[La+3]. | |
| Lanthanum carbonate hydrate | Lanthanum carbonate hydrate. Category: Hypoglycemic apis. CAS No. 929207-29-4. Product ID: API929207294. | |
| Lapatinib | Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity. Lapatinib has antitumor activity and can be used to treat advanced or metastatic breast cancer with HER2 overexpression. Category: Active pharmaceutical ingredients. CAS No. 231277-92-2. Product ID: API231277922. Molecular formula: C29H26ClFN4O4S. Mole weight: 581.06. | |
| Lapatinib Ditosylate | Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2). Category: Active pharmaceutical ingredients. Synonyms: Tykerb ditosylate, Lapatinib (GW-572016) Ditosylate, GW-572016 ditosylate. CAS No. 388082-77-7. Product ID: API388082777. Molecular formula: C29H26ClFN4O4S·2C7H8O3S. Mole weight: 925.46. | |
| Lapatinib tosylate | Lapatinib tosylate (GW572016), a robust and orally administered inhibitor specifically targeting the tyrosine kinase domains of ErbB-2 and EGFR, exhibits inhibitory concentration 50 (IC50) values of 10.2 nM and 9.8 nM against purified EGFR and ErbB-2, respectively. Category: Active pharmaceutical ingredients. Synonyms: GW2016 tosylate. CAS No. 1187538-35-7. Product ID: API1187538357. Molecular formula: C36H34ClFN4O7S2. Mole weight: 753.26. | |
| Laropiprant analog | Laropiprant analog is an antagonist of the prostaglandin PGD2 receptor DP1. Category: Active pharmaceutical ingredients. CAS No. 2043025-96-1. Product ID: API2043025961. Molecular formula: C20H18ClFN2O4S. Mole weight: 436.88. | |
| LaropiprantMK-0524 | Laropiprant (MK-0524) is a potent and selective antagonist of prostaglandin D2 (PGD2) receptor (DP) such as and DP/DP1 receptor(Ki = 0.57 nM) and TP Receptor(Ki = 2.95 nM). Category: Active pharmaceutical ingredients. CAS No. 571170-77-9. Product ID: API571170779. Molecular formula: C21H19ClFNO4S. Mole weight: 435.9. | |
| Larotrectinib | Larotrectinib (LOXO-101) is an orally administered inhibitor of the TRK kinase, demonstrating high selectivity exclusively for the TRK family of receptors (IC50s = 2-20 nM). Category: Active pharmaceutical ingredients. CAS No. 1223403-58-4. Product ID: API1223403584. Molecular formula: C21H22F2N6O2. Mole weight: 428.44. | |
| Larotrectinib sulfate | Larotrectinib sulfate (LOXO-101 sulfate) is an oral active and specific ATP-competitive inhibitor of tropomyosin receptor kinases (TRK). Category: Active pharmaceutical ingredients. CAS No. 1223405-08-0. Product ID: API1223405080. Molecular formula: C21H22F2N6O2·H2O4S. Mole weight: 526.51. | |
| Lascufloxacin | Lascufloxacin, a potent and orally active fluoroquinolone antibacterial agent, holds potential for the treatment of various infectious diseases, including lower respiratory tract infections. It effectively inhibits infections caused by a wide range of pathogens, encompassing those resistant to quinolones. Category: Active pharmaceutical ingredients. CAS No. 848416-07-9. Product ID: API848416079. Molecular formula: C21H24F3N3O4. Mole weight: 439.43. | |
| Lascufloxacin HCl | Lascufloxacin (KRP-AM-1977) is a potent antibacterial drug candidate. It exhibited the most potent activity against gram-positive bacteria among the quinolones tested. Lascufloxacin showed incomplete cross-resistance against existing quinolone-resistant s. Category: Active pharmaceutical ingredients. CAS No. 1433857-09-0. Product ID: API1433857090. Molecular formula: C21H25ClF3N3O4. Mole weight: 475.89. | |
| Latanoprost | Latanoprost is a synthetic prostaglandin F2-alpha analogue and a first-line topical agent for the reduction of intraocular pressure. It is formulated as a sterile ophthalmic solution administered once daily, representing one of the most widely prescribed medications for glaucoma worldwide. The compound is a prodrug designed to enhance corneal penetration through esterification of the parent prostaglandin. Applications: It is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension. as a first-line agent, it offers the advantage of once-daily dosing with excellent 24-hour efficacy, including consistent pressure control during the nocturnal period. common adverse effects include dose-dependent increases in iris pigmentation, eyelash growth, and periorbital fat atrophy. Category: Ophthalmic apis. Synonyms: Xalatan; PhXA41; latanoprostum; propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate; 6Z5B6HVF6O. CAS No. 130209-82-4. Product ID: API130209824. Molecular formula: C26H40O5. Mole weight: 432.6. EINECS: 634-172-9. InChIKey: GGXICVAJURFBLW-CEYXHVGTSA-N. Appearance: Light yellow oily liquid. | |
| L-Carnitine tartrate | L-Carnitine tartrate. Category: Veterinary products. Synonyms: L-Carnitine-L-tartra;QV1YQ1K1&1&1 &&R Form tartrate 2:1);MFCD00799250;L-Carnitine L-Tartrate;L-Carnitine tartarate;Bis[(2R)-3-carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium] (2R,3R)-2,3-dihydroxysuccinate;L-CARNITINE-1-TARTRATE;L-Carnitine L-Tartr;Vitamin BT L-tartrate;Bis[[(R)-3-carboxy-2-hydroxypropyl]trimethylammonium] L-Tartrate;Magnesium salt L-ascorbic acid phosphate;L-Carnitine tartrate;L-CARNITINETARTRATE,POWDER;L-Carnitine-L-tartrate. CAS No. 36687-82-8. Product ID: PIVF-0059. Molecular formula: C11H18NO8-. Mole weight: 472.485. Appearance: White to Almost white powder to crystal. | |
| Ledipasvir | Ledipasvir (GS-5885) is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor. Category: Active pharmaceutical ingredients. CAS No. 1256388-51-8. Product ID: API1256388518. Molecular formula: C49H54F2N8O6. Mole weight: 889. | |
| Ledipasvir D-tartrate | Ledipasvir D-tartrate with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon. is an inhibitor of the hepatitis C virus NS5A. Category: Active pharmaceutical ingredients. CAS No. 1502654-87-6. Product ID: API1502654876. Molecular formula: C53H60F2N8O12. Mole weight: 1039.104. | |
| Ledipasvir hydrochloride | Ledipasvir hydrochloride is a hepatitis C virus NS5A inhibitor, demonstrating potent activity with EC50 values of 34 pM for genotype 1a replicon and 4 pM for genotype 1b replicon. It also functions as a SARS-CoV 3CL pro inhibitor with an IC50 of 1.62 μM. Category: Active pharmaceutical ingredients. CAS No. 2128695-48-5. Product ID: API2128695485. Molecular formula: C49H55ClF2N8O6. Mole weight: 925.46. | |
| L-Eflornithine | L-Eflornithine is an irreversible ornithine decarboxylase (ODC) inhibitor with a KD of 1.3±0.3 μM, and a Kinact of 0.15±0.03 min-1. L-Eflornithine is an enantiomer of Eflornithine. Category: Active pharmaceutical ingredients. Synonyms: L-α-difluoromethylornithine, L-RMI71782, L-DFMO. CAS No. 66640-93-5. Product ID: API66640935. Molecular formula: C6H12F2N2O2. Mole weight: 182.17. | |
| L-Eflornithine monohydrochloride | L-Eflornithine is an irreversible ornithine decarboxylase (ODC) inhibitor with a KD of 1.3±0.3 μM, and a Kinact of 0.15±0.03 min-1. L-Eflornithine monohydrochloride (L-DFMO monohydrochloride) is an enantiomer of Eflornithine. Category: Active pharmaceutical ingredients. CAS No. 69955-42-6. Product ID: API69955426. Molecular formula: C6H13ClF2N2O2. Mole weight: 218.63. | |
| Leflunomide | Leflunomide (HWA486) is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis. Category: Active pharmaceutical ingredients. Synonyms: SU101, RS-34821, HWA486. CAS No. 75706-12-6. Product ID: API75706126. Molecular formula: C12H9F3N2O2. Mole weight: 270.21. | |
| Leflunomide-d4 | Leflunomide-d4 is a deuterated compound of Leflunomide. Leflunomide has a CAS number of 75706-12-6. Leflunomide is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis. Category: Active pharmaceutical ingredients. CAS No. 1189987-23-2. Product ID: API1189987232. Molecular formula: C12H5D4F3N2O2. Mole weight: 274.23. | |
| Leflunomide EP Impurity B-d4 | Leflunomide EP Impurity B-d4 is a deuterated compound of Leflunomide EP Impurity B. Leflunomide EP Impurity B has a CAS number of 163451-81-8. Teriflunomide is the principal active metabolite of leflunomide, an approved therapy for rheumatoid arthritis and multiple sclerosis. Category: Active pharmaceutical ingredients. CAS No. 1185240-22-5. Product ID: API1185240225. Molecular formula: C12H5D4F3N2O2. Mole weight: 274.23. | |
| Leniolisib | Leniolisib has the potential for immunodeficiency disorders treatment. Category: Active pharmaceutical ingredients. Synonyms: CDZ173. CAS No. 1354690-24-6. Product ID: API1354690246. Molecular formula: C21H25F3N6O2. Mole weight: 450.46. | |
| Lesinurad | Used for treatment of gout. It has a role as a uricosuric drug. Category: Active pharmaceutical ingredients. Synonyms: RDEA594. RDEA 594. Zurampic. CAS No. 878672-00-5. Product ID: API878672005. Molecular formula: C17H14BrN3O2S. Mole weight: 404.3. EINECS: 689-245-8. SMILES: C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O. Appearance: White to Off-white Solid. | |
| Levetiracetam | Levetiracetam is a compound which inhibits burst firing without affecting normal neuronal excitability. Category: Active pharmaceutical ingredients. CAS No. 102767-28-2. Product ID: API102767282. Molecular formula: C8H14N2O2. Mole weight: 170.21. Appearance: Crystalline. | |
| Levobupivacaine HCL | S-enantiomer of bupivacaine that is used as a local anesthetic and for regional nerve blocks, including EPIDURAL ANESTHESIA. Category: Anesthetic analgesia apis. Synonyms: Levobupivacaine hydrochloride. Chirocaine. Bupicaine hydrochloride (-). CAS No. 27262-48-2. Product ID: API27262482. Molecular formula: C18H29ClN2O. Mole weight: 324.9. EINECS: 642-955-1. SMILES: CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl. Standard: In-House. | |
| Levocabastine hydrochloride | Levocabastine HCl is an agent with antihistaminic activity. Category: Active pharmaceutical ingredients. CAS No. 79547-78-7. Product ID: API79547787. Molecular formula: C26H30ClFN2O2. Mole weight: 456.98. | |
| LevocabastineLivostin,Bilina | Levocarbastine is a second-generation H1 receptor antagonist for allergic conjunctivitis. It also acts as a potent selective antagonist for the neurotensin receptor NTS2 and is the first drug to be used to characterize different neurotensin subtypes. Category: Active pharmaceutical ingredients. CAS No. 79516-68-0. Product ID: API79516680. Molecular formula: C26H29FN2O2. Mole weight: 420.52. | |
| Levocarnitine | Levocarnitine (L-carnitine) is a naturally occurring amino acid derivative essential for mitochondrial fatty acid oxidation. It is available for replacement therapy in primary and secondary carnitine deficiencies. The compound is synthesized endogenously in the liver and kidneys but may become depleted in certain disease states. Applications: Levocarnitine is indicated for the treatment of primary systemic carnitine deficiency, a rare genetic disorder of the carnitine transporter. it is also used for secondary deficiency in patients with end-stage renal disease on hemodialysis, those receiving valproic acid therapy, or individuals with organic acidurias. intravenous administration is reserved for acute metabolic crises, while oral maintenance therapy prevents cardiomyopathy, myopathy, and hypoglycemia in deficient patients. Category: Active pharmaceutical ingredients. Synonyms: ME3-GAMMA-ABU(BETA-HYDROXY)-OH; (R)-BETA-HYDROXY-GAMMA-(TRIMETHYLAMMONIO)BUTYRATE; (R)-3-HYDROXY-4-(TRIMETHYLAMMONIO)BUTYRATE; L-Carnitine; Tartrate; L-carnitine; Vitamin BT; L-ca greatrnitine; L-ctheirrnitine. CAS No. 541-15-1. Product ID: API541151. Molecular formula: C7H15NO3. Mole weight: 161.2. EINECS: 208-768-0. InChIKey: PHIQHXFUZVPYII-ZCFIWIBFSA-N. Appearance: White crystalline hygroscopic powder. | |
| Levodopa | Levodopa (L-DOPA) is an orally active, metabolic precursor to the neurotransmitter dopamine, a direct product of the action of the enzyme tyrosine hydroxylase. It is a catecholamine that is the direct precursor to dopamine and norepinephrine, and a widely used as a treatment for Parkinson's syndrome. Applications: Levodopa is primarily used for the treatment of parkinson's disease, for which it is one of the most effective drugs. it is also used to improve brain function in hepatic encephalopathy. it may also have a role in increasing bone density, though the latter is yet to be defined. Category: Active pharmaceutical ingredients. Synonyms: 2-amino-3-(3,4-dihydroxyphenyl)propanoicacid; 3,4-Dihydroxyphenylalanine(form2); L-DOPA. CAS No. 59-92-7. Product ID: API59927. Molecular formula: C9H11NO4. Mole weight: 197.19. EINECS: 200-445-2. InChIKey: WTDRDQBEARUVNC-LURJTMIESA-N. Appearance: Crystalline powder. | |
| Levofloxacin | Levofloxacin is a broad-spectrum synthetic antibiotic belonging to the fluoroquinolone class, and it is a third-generation quinolone antibacterial drug. Levofloxacin is the levorotatory isomer of ofloxacin and has extremely low toxicity and side effects. Applications: Levofloxacin is clinically indicated for a spectrum of bacterial infections. its primary applications encompass:; respiratory tract infections, including community-acquired pneumonia, acute bacterial exacerbations of chronic bronchitis, and acute bacterial sinusitis.; urinary tract infections, treating both complicated and uncomplicated cases, such as acute pyelonephritis.; skin and skin structure infections, specifically uncomplicated bacterial presentations.; other key uses, including the management of bacterial prostatitis and post-exposure inhalational anthrax. Category: Fluorine-containing apis. CAS No. 100986-85-4. Product ID: API100986854. Molecular formula: C18H20FN3O4. Mole weight: 361.37. | |
| Levofloxacin-d8 | Levofloxacin-d8 is a deuterated compound of Levofloxacin. Levofloxacin has a CAS number of 100986-85-4. Levofloxacin is a broad-spectrum antibiotic topoisomerase II and topoisomerase IV inhibitor, used to treat respiratory, urinary tract, gastrointestinal, and abdominal infections. Category: Active pharmaceutical ingredients. CAS No. 1217716-71-6. Product ID: API1217716716. Molecular formula: C18H12D8FN3O4. Mole weight: 369.42. | |
| Levofloxacin hydrochloride | Levofloxacin is a broad-spectrum,third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin diffuses through the bacterial cell wall and acts by inhibiting DNA gyrase (bacterial topoisomerase II),an enzyme required for DNA replication,RNA transcription,and repair of bacterial DNA. Inhibition of DNA gyrase activity leads to blockage of bacterial cell growth. Category: Active pharmaceutical ingredients. CAS No. 177325-13-2. Product ID: API177325132. Molecular formula: C18H21ClFN3O4. Mole weight: 397.8. | |
| Levofloxacin Hydrochloride Impurity A | Levofloxacin Hydrochloride Impurity A I, one of the quinolones, has a broad spectrum of antibacterial action. Category: Active pharmaceutical ingredients. CAS No. 2254176-11-7. Product ID: API2254176117. Molecular formula: C18H21ClFN3O4. Mole weight: 397.83. | |
| Levofloxacin N-oxide | Levofloxacin N-oxide is an inactive metabolite of the antibiotic levofloxacin. Levofloxacin N-oxide is also a degradation product of levofloxacin that is formed through exposure to daylight or hydrogen peroxide. Category: Active pharmaceutical ingredients. CAS No. 117678-38-3. Product ID: API117678383. Molecular formula: C18H20FN3O5. Mole weight: 377.37. | |
| Levofloxacin sodium | Levofloxacin sodium is a synthetic fluoroquinolones antibacterial. It inhibits the supercoiling activity of bacterial DNA gyrase, so that halting DNA replication. Category: Active pharmaceutical ingredients. CAS No. 872606-49-0. Product ID: API872606490. Molecular formula: C18H20FN3NaO4. Mole weight: 384.363. | |
| Levonadifloxacin | Levonadifloxacin ((S)-(-)-Nadifloxacin; WCK 771), a broad-spectrum anti-staphylococcal agent, exhibits antibacterial activity against both Methicillin-susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant S. aureus (MRSA) strains, effectively reducing these bacteria when phagocytosed by THP-1 monocytes. Category: Active pharmaceutical ingredients. CAS No. 154357-42-3. Product ID: API154357423. Molecular formula: C19H21FN2O4. Mole weight: 360.38. | |
| Levonadifloxacin arginine | Levonadifloxacin arginine ((S)-(-)-Nadifloxacin; WCK 771) is a broad-spectrum anti-staphylococcal agent. It exhibits antibacterial activity against both methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus. Additionally, it reduces monocyte THP-1 phagocytosis of MRSA and MSSA strains. Category: Active pharmaceutical ingredients. Synonyms: (S)-(-)-Nadifloxacin arginine,WCK 771 arginine. CAS No. 306748-89-0. Product ID: API306748890. Molecular formula: C25H35FN6O6. Mole weight: 534.58. | |
| Levonadifloxacin Arginine Salt | Levonadifloxacin, a broad-spectrum fluoroquinolone antibiotic, is used potentially for the treatment of staphylococci. Category: Active pharmaceutical ingredients. Synonyms: WCK 771,WCK-771A,WCK 771A,WCK-771,WCK771A,WCK771. CAS No. 627891-34-3. Product ID: API627891343. Molecular formula: C25H37FN6O7. Mole weight: 552.6. | |
| Levonebivolol | Levonebivolol (R 67145) is an enantiomer of nepirolol, a β1 blocker with nitric oxide vasodilators for the treatment of hypertension. Category: Active pharmaceutical ingredients. Synonyms: R 67145. CAS No. 118457-16-2. Product ID: API118457162. Molecular formula: C22H25F2NO4. Mole weight: 405.43. | |
| L-Glutathione | Glutathione Oxidized (GSSG) is widely founded in organisms, mainly play a role of oxidation reduction electron transfer. lt can protect the red blood cells in the blood from oxidative damage, maintenance of hemoglobin in the cysteine in a reduced state. Category: Cosmetic ingredients and additives. Synonyms: n-(n-gamma-glutamyl-cysteinyl)glycine-(2,2)-disulfide;N,N-[dithiobis[1-[(carboxymethyl)carbamoyl]ethylene]]di-,L-Glutamine;n-(dithiobis(1-((carboxymethyl)carbamoyl)ethylene))di-l-glutamin;oxidizedglutathione. CAS No. 27025-41-8. Product ID: CIA27025418. Molecular formula: C20H32N6O12S2. Mole weight: 612.63. EINECS: 248-170-7. InChIKey: YPZRWBKMTBYPTK-USZNOCQGSA-N. Appearance: Powder. | |
| Lidocaine Hydrochloride | A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. Category: Antiarrhythmic apis. Synonyms: Lidocaine hydrochloride monohydrate. Zingo. Linocaine hydrochloride. Lignocaine hydrochloride. CAS No. 6108-05-0. Product ID: API6108050. Molecular formula: C14H25ClN2O2. Mole weight: 288.81. EINECS: 612-079-4. SMILES: CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.O.Cl. | |
| Lidoflazine | Lidoflazine is a high-affinity blocker of the HERG K+ channel and is an antianginal calcium channel blocker. It carries an obvious risk of QT interval prolongation and ventricular arrhythmia. Category: Active pharmaceutical ingredients. CAS No. 3416-26-0. Product ID: API3416260. Molecular formula: C30H35F2N3O. Mole weight: 491.62. | |
| Limonin | Limonin is a triterpenoid enriched in citrus fruits, which has antivirus and antitumor ability.IC50 Value: Target: HIV; anticancerLimonin is a triterpenoid aglycone that is a bitter principle of citrus fruits. Limonin is chemically induced carcinogenesis inhibitor and HIV-1 replication inhibitor. Limonin has anti-proliferative, proapoptotic activity on several cancer cell lines and inhibits azoxymethane-induced colon cancer in rats. Limonin also inhibits HIV-1 replication in culturedf monocytes, macrophages, and mononuclear cells, perhaps by inhibition of HIV-1 protease activity. Category: Active pharmaceutical ingredients. CAS No. 1180-71-8. Product ID: API1180718. Molecular formula: C26H30O8. Mole weight: 470.512. | |
| Linear Alkyl Benzene Sulphonic Acid, LABSA 96% | Linear Alkyl Benzene Sulphonic Acid, or LABSA for short, has been the world's largest-volume synthetic surfactant used in the detergent industry for decades. It's a very cost-effective anionic surfactant with excellent cleaning power and compatibility with other types of surfactants. Category: Chemicals. Synonyms: p-(3-Dodecyl)benzenesulphonic acid. Benzenesulfonic acid, 4-(1-ethyldecyl)-. p-(3-Dodecyl)benzenesulfonic acid. CAS No. 27176-87-0. Product ID: CHE27176870. Molecular formula: CH3(CH2)11C6H4SO3H. Mole weight: 326.5. EINECS: 242-564-2. SMILES: CCCCCCCCCC(CC)C1=CC=C(C=C1)S(=O)(=O)O. | |
| Linezolid-d3 | Linezolid D3, a deuterium-labeled version of Linezolid, is a synthetic antibiotic designed to halt the initiation of bacterial protein synthesis. Category: Active pharmaceutical ingredients. CAS No. 1127120-38-0. Product ID: API1127120380. Molecular formula: C16H20FN3O4. Mole weight: 340.36. | |
| Liraglutide | Liraglutide is a synthetic analog of human glucagon-like peptide-1 (GLP-1) and a GLP-1 receptor agonist, administered via once-daily subcutaneous injection. Structurally, it shares 97% homology with human GLP-1 and is designed to resist rapid degradation by dipeptidyl peptidase-4, extending its half-life for once-daily dosing. Applications: Liraglutide is fda-approved to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes, as an adjunct to diet and exercise. beyond glycemic and weight effects, liraglutide provides cardiovascular benefits by reducing major adverse cardiovascular events and slows progression of diabetic kidney disease in high-risk patients. Category: Peptide apis. Synonyms: NN2211, Saxenda. CAS No. 204656-20-2. Product ID: API0232951. Molecular formula: C172H265N43O51. Mole weight: 3751. EINECS: 810-818-7. InChIKey: YSDQQAXHVYUZIW-QCIJIYAXSA-N. | |
| Liranaftate | Liranaftate is a squalene epoxidase inhibitor with anti-fungicidal activities. Category: Active pharmaceutical ingredients. CAS No. 88678-31-3. Product ID: API88678313. Molecular formula: C18H20N2O2S. Mole weight: 328.43. | |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine dimesylate is a central nervous system stimulant and the first chemically formulated prodrug stimulant approved for therapeutic use. It is available as capsules and chewable tablets in various strengths for oral administration and is classified as a Schedule II controlled substance due to its high potential for abuse and dependence. Applications: Lisdexamfetamine dimesylate is fda-approved for the treatment of attention-deficit/hyperactivity disorder in adults and pediatric patients six years and older, and for moderate to severe binge eating disorder in adults. the typical starting dose is 30 mg once daily in the morning, titrated up to a maximum of 70 mg daily as needed. due to its abuse potential, therapy requires careful patient selection and monitoring for signs of misuse, dependence, and cardiovascular effects. Category: Amino acids and derivatives. Synonyms: Lisdexamfetamine mesilate; NRP104; SPD489. CAS No. 608137-33-3. Product ID: API0232126. Molecular formula: C17H33N3O7S2. Mole weight: 455.59. InChIKey: CETWSOHVEGTIBR-FORAGAHYSA-N. | |
| Lixisenatide | Lixisenatide is used together with diet and exercise to help control your blood sugar. This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. Category: Active pharmaceutical ingredients. CAS No. 320367-13-3. Product ID: API320367133. Molecular formula: C215H347N61O65S. Mole weight: 4858.53. InChIKey: XVVOERDUTLJJHN-JXBMKTOPNA-N. | |
| L-Lysine Acetate | An essential amino acid. It is often added to animal feed. Category: Amino acids and derivatives. Synonyms: Lysine acetate. L-LYSINE ACETATE SALT. L-Lysine monoacetate. CAS No. 57282-49-2. Product ID: API57282492. Molecular formula: C8H18N2O4. Mole weight: 206.24. EINECS: 257-845-5. SMILES: CC(=O)O.C(CCN)CC(C(=O)O)N. Appearance: White crystalline powder. Standard: USP,AJI,EP,CP. | |
| L-Lysine-L-Aspartate | L-Lysine-L-Aspartate. Category: Amino acids and derivatives. Synonyms: L-Lysine-L-aspartate. L-Lysine L-Aspartate. Lysine aspartate. (S)-2,6-Diaminohexanoic acid compound with (S)-2-aminosuccinic acid (1:1). CAS No. 27348-32-9. Product ID: API27348329. Molecular formula: C10H21N3O6. Mole weight: 279.29. EINECS: 248-423-1. SMILES: C(CCN)CC(C(=O)O)N.C(C(C(=O)O)N)C(=O)O. Appearance: White crystals or crystalline. Standard: AJI. | |
| L-Lysine-L-Glutamate | L-Lysine-L-Glutamate. Category: Amino acids and derivatives. Synonyms: Lysine glutamate. L-Lysine L-glutamate salt. (S)-2,6-Diaminohexanoic acid (S)-2-aminopentanedioic acid. CAS No. 5408-52-6. Product ID: API5408526. Molecular formula: C11H23N3O6. Mole weight: 293.32. EINECS: 226-474-0. SMILES: C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N. Standard: AJI. | |
| L-Mabuterol HCl | L-Mabuterol HCl is a selective agonist of β2 adrenoreceptor. Category: Active pharmaceutical ingredients. CAS No. 95656-55-6. Product ID: API95656556. Molecular formula: C13H19Cl2F3N2O. Mole weight: 347.2. | |
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.